Yoga for adults with type 2 diabetes: A systematic review of controlled trials

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Innes, Kim E ^a,b   Selfe, Terry Kit ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE; BODY COMPOSITION; CINAHL; CLINICAL ASSESSMENT TOOL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MEDLINE; MOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PEDRO SCALE; PRIORITY JOURNAL; PSYCINFO; PUBLICATION; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVIEW; SLEEP; SYSTEMATIC REVIEW; YOGA; ADOLESCENT; ADULT; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; LIPIDS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOGA; YOUNG ADULT;

EID: 84953897530     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/6979370     Document Type: Review

References (166)

1. D. W. Lamand D. LeRoith, "The worldwide diabetes epidemic," Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 2, pp. 93-96, 2012.
2. L. Chen, D. J. Magliano, and P. Z. Zimmet, "The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives," Nature Reviews Endocrinology, vol. 8, no. 4, pp. 228-236, 2012.
3. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., "Managementof hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)," Diabetes care, vol. 35, no. 6, pp. 1364-1379, 2012.
4. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 2011.
5. M. J. Fowler, "Microvascular and macrovascular complications of diabetes," Clinical Diabetes, vol. 29, no. 3, pp. 116-122, 2011.
6. American Diabetes Association, "Standards of medical care in diabetes-2014," Diabetes Care, vol. 37, supplement 1, pp. S14-S80, 2014.
7. J. J. Joseph and S. H. Golden, "Type 2 diabetes and cardiovascular disease: what next?" Current Opinion in Endocrinology, Diabetes and Obesity, vol. 21, no. 2, pp. 109-120, 2014.
8. American Heart Association, Cardiovascular Disease and Diabetes, 2012, http://www.heart.org/HEARTORG/Conditions/ Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes UCM 313865 Article. jsp/.
9. M. Petersen, "Economic costs of diabetes in the US in 2012," Diabetes Care, vol. 36, no. 4, pp. 1033-1046, 2012.
10. K. E. Innes and H. K. Vincent, "The influence of yogabased programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review," Evidence-based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 469-486, 2007.
11. K. E. Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes," Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.
12. J. S. Rana, M. Nieuwdorp, J. W. Jukema, and J. J. P. Kastelein, "Cardiovascular metabolic syndrome-an interplay of, obesity, inflammation, diabetes and coronary heart disease," Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 218-232, 2007.
13. K.-H. Yoon, J.-H. Lee, J.-W. Kim et al., "Epidemic obesity and type 2 diabetes in Asia," The Lancet, vol. 368, no. 9548, pp. 1681-1688, 2006.
14. P. Zimmet, J. Shaw, S. Murray, and R. Sicree, "Diabetes: an epidemic in full flight: forecasting the future," Bulletin of the International Diabetes Federation, vol. 48, pp. 12-16, 2003.
15. F. B. Hu, "Globalization of diabetes. The role of diet, lifestyle, and genes," Diabetes Care, vol. 34, no. 6, pp. 1249-1257, 2011.
16. F. P. Cappuccio, L. DElia, P. Strazzullo, and M. A. Miller, "Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis," Diabetes Care, vol. 33, no. 2, pp. 414-420, 2010.
17. M. T. U. Barone and L. Menna-Barreto, "Diabetes and sleep: a complex cause-and-effect relationship," Diabetes Research and Clinical Practice, vol. 91, no. 2, pp. 129-137, 2011.
18. C.-C. Lin, C.-I. Li, C.-S. Liu et al., "Impact of lifestyle-related factors onall-cause and cause-specificmortality inpatientswith type 2 diabetes: the Taichung diabetes study," Diabetes Care, vol. 35, no. 1, pp. 105-112, 2012.
19. S. A. Black, K. S. Markides, and L. A. Ray, "Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes," Diabetes Care, vol. 26, no. 10, pp. 2822-2828, 2003.
20. E. Atlantis, P. Fahey, and J. Foster, "Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis," BMJ Open, vol. 4, no. 4, Article ID e004706, 2014.
21. E. A. Beverly, "Stressing the importance of diabetes distress: a comment on Baek et al," Annals of Behavioral Medicine, vol. 48, no. 2, pp. 137-139, 2014.
22. D. G. Bruce, W. A. Davis, S. E. Starkstein, and T. M. E. Davis, "A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study," Diabetologia, vol. 48, no. 12, pp. 2532-2539, 2005.
23. D. Hessler, L. Fisher, R. E. Glasgow et al., "Reductions in regimen distress are associatedwith improved management and glycemic control over time," Diabetes Care, vol. 37, no. 3, pp. 617-624, 2014.
24. S. A. Safren, J. S. Gonzalez, D. J. Wexler et al., "A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes," Diabetes Care, vol. 37, no. 3, pp. 625-633, 2014.
25. L. Fishman and E. Saltonstall, "Yoga in pain management," in Integrative Pain Medicine: The Science and Practice of Complementary and Alternative Medicine in Pain Management, pp. 259-284, Humana Press, 2008.
26. M. Garfinkel and H. R. Schumacher, "Yoga," Rheumatic Disease Clinics of North America, vol. 26, no. 1, pp. 125-132, 2000.
27. K. Chandler, "The emerging field of yoga therapy," Hawaii Medical Journal, vol. 60, no. 11, pp. 286-287, 2001.
28. J. A. Raub, "Psychophysiologic effects of Hatha Yoga onmusculoskeletal and cardiopulmonary function: a literature review," Journal of Alternative and Complementary Medicine, vol. 8, no. 6, pp. 797-812, 2002.
29. C. K. Chappie, "Modern yoga," Religious Studies Review, vol. 34, no. 2, pp. 71-76, 2008.
30. P. E. Jeter, J. Slutsky, N. Singh, and S. B. Khalsa, "Yoga as a therapeutic intervention: a bibliometric analysis of published research studies from 1967 to 2013," The Journal of Alternative and Complementary Medicine, 2015.
31. A. Ross and S. Thomas, "The health benefits of yoga and exercise: a review of comparison studies," Journal of Alternative and Complementary Medicine, vol. 16, no. 1, pp. 3-12, 2010.
32. A. Büssing, A. Michalsen, S. B. S. Khalsa, S. Telles, and K. J. Sherman, "Effects of yoga on mental and physical health: a short summary of reviews," Evidence-Based Complementary and AlternativeMedicine, vol. 2012, Article ID 165410, 7 pages, 2012.
33. N. K. Patel, A. H. Newstead, and R. L. Ferrer, "The effects of yoga on physical functioning and health related quality of life in older adults: a systematic review and meta-analysis," Journal of Alternative and Complementary Medicine, vol. 18, no. 10, pp. 902-917, 2012.
34. H. Cramer, R. Lauche, H. Haller, N. Steckhan, A. Michalsen, and G. Dobos, "Effects of yoga on cardiovascular disease risk factors: a systematic review andmeta-analysis," International Journal of Cardiology, vol. 173, no. 2, pp. 170-183, 2014.
35. L. A. Uebelacker, G. Epstein-Lubow, B. A. Gaudiano, G. Tremont, C. L. Battle, and I. W. Miller, "Hatha yoga for depression: Critical review of the evidence for efficacy, plausible mechanisms of action, and directions for future research," Journal of Psychiatric Practice, vol. 16, no. 1, pp. 22-33, 2010.
36. M. Balasubramaniam, S. Telles, and P. M. Doraiswamy, "Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders," Frontiers in Psychiatry, vol. 3, article 117, 2013.
37. H. Cramer, R. Lauche, J. Langhorst, and G. Dobos, "Yoga for depression: a systematic review and meta-analysis," Depression and Anxiety, vol. 30, no. 11, pp. 1068-1083, 2013.
38. K. Khare and D. Jain, "Effect of yoga on plasma glucose and serum fructosamine level in NIDDM," Yoga Mimamsa, vol. 33, pp. 1-9, 1999.
39. M. Bindra, S. Nair, and S. Darotiya, "Influence of pranayamas and yoga-asanas on blood glucose, lipid profile and HbA1c in type 2 diabetes," International Journal of Pharma and Bio Sciences, vol. 4, no. 1, pp. 169-172, 2013.
40. V. V. Agte and K. Tarwadi, "Sudarshan kriya yoga for treating type 2 diabetes: a preliminary study," Alternative and ComplementaryTherapies, vol. 10, no. 4, pp. 220-222, 2004.
41. H. H. Mahapure, S. U. Shete, and T. K. Bera, "Effect of yogic exercise on super oxide dismutase levels in diabetics," International Journal of Yoga, vol. 1, no. 1, pp. 21-26, 2008.
42. S. Dash and A. K. Thakur, "Effect of yoga in patients with type-II diabetes mellitus," Journal of Evolution ofMedical andDental Sciences, vol. 3, no. 7, pp. 1642-1655, 2014.
43. U. Popli, C. P. Subbe, and K. Sunil, "Research letter-the role of yoga as a lifestyle modification in treatment of diabetes mellitus: results of a pilot study," Alternative Therapies in Health and Medicine, vol. 20, no. 6, pp. 24-26, 2014.
44. P. A. Balaji, S. R. Varne, and S. S. Ali, "Effects of yoga-pranayama practices on metabolic parameters and anthropometry in type 2 diabetes," InternationalMultidisciplinary Research Journal, vol. 1, no. 10, pp. 1-4, 2011.
45. S. V. Hegde, P. Adhikari, S. Kotian, V. J. Pinto, S. DSouza, and V. DSouza, "Effect of 3-month yoga on oxidative stress in type diabetes with or without complications: a controlled clinical trial," Diabetes Care, vol. 34, no. 10, pp. 2208-2210, 2011.
46. T. Kyizom, S. Singh, K. P. Singh, O. P. Tandon, and R. Kumar, "Effect of pranayama and yoga-asana on cognitive brain functions in type 2 diabetes-P3 event related evoked potential (ERP)," Indian Journal of Medical Research, vol. 131, no. 5, pp. 636-640, 2010.
47. V. Malhotra, S. Singh, S. B. Sharma et al., "The status ofNIDDM patients after yoga asanas: assessment of important parameters," Journal of Clinical and Diagnostic Research, vol. 4, no. 3, pp. 2652-2667, 2010.
48. S. Singh, T. Kyizom, K. P. Singh, O. P. Tandon, and S. V. Madhu, "Influence of pranayamas and yoga-asanas on serum insulin, bloodglucose andlipidprofile in type2diabetes," Indian Journal of Clinical Biochemistry, vol. 23, no. 4, pp. 365-368, 2008.
49. R. Agrawal, R. Aradhana, S. Hussain, R. Beniwal, M. Sabir, and D. Kochar, "Influence of yogic treatment on quality of life outcomes, glycaemic control and risk factors in diabetes mellitus," International Journal of Diabetes in Developing Countries, vol. 23, pp. 130-134, 2003.
50. V. Malhotra, S. Singh, O. P. Tandon, S. V. Madhu, A. Prasad, and S. B. Sharma, "Effect of Yoga asanas on nerve conduction in type diabetes," Indian Journal of Physiology and Pharmacology, vol. 46, no. 3, pp. 298-306, 2002.
51. N. Habibi and S. Marandi, "Effect of 12 weeks of yoga practice on glucose, insulin and triglycerides serum level in women with diabetes type II," Journal of Gorgan University of Medical Sciences, vol. 15, no. 4, pp. 1-7, 2014.
52. N. Habibi, Z. Farsani, B. Yazdani, R. Arianshakib, and P. Noruozi, "The influence of yoga on risk profiles programs in women with diabetes type II," Advances in Environmental Biology, vol. 7, no. 4, pp. 550-555, 2013.
53. V. P. Jyotsna, A. Dhawan, V. Sreenivas, K. K. Deepak, and R. Singla, "Completion report: effect of Comprehensive Yogic Breathing program on type 2 diabetes: a randomized control trial," Indian Journal of Endocrinology and Metabolism, vol. 18, no. 4, pp. 582-584, 2014.
54. V. P. Jyotsna, S. Ambekar, R. Singla et al., "Cardiac autonomic function in patients with diabetes improves with practice of comprehensive yogic breathing program," Indian Journal of Endocrinology andMetabolism, vol. 17, no. 3, pp. 480-485, 2013.
55. V. P. Jyotsna, S. Ambekar, A. Joshi et al., "Prospective randomized controlled intervention trial: comprehensive yogic breathing program improves cardiac autonomic functions and quality of life in diabetes," Indian Journal of Endocrinology and Metabolism, vol. 16, supplement 2, pp. S489-S491, 2012.
56. V. P. Jyotsna, A. Joshi, S. Ambekar, N. Kumar, A. Dhawan, and V. Sreenivas, "Comprehensive yogic breathing program improves quality of life in patientswith diabetes," Indian Journal of Endocrinology and Metabolism, vol. 16, no. 3, pp. 423-428, 2012.
57. R. Nagarathna, M. R. Usharani, A. R. Rao, R. Chaku, R. Kulkarni, and H. R. Nagendra, "Efficacy of yoga based life style modification program on medication score and lipid profile in type 2 diabetes-a randomized control study," International Journal of Diabetes in Developing Countries, vol. 32, no. 3, pp. 122-130, 2012.
58. N. Shantakumari, S. Sequeira, and R. El Deeb, "Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia," Indian Heart Journal, vol. 65, no. 2, pp. 127-131, 2013.
59. N. Shantakumari, S. Sequeira, and R. Eldeeb, "Effect of a yoga intervention on hypertensive diabetic patients," Journal of Advances in Internal Medicine, vol. 1, no. 2, pp. 60-63, 2012.
60. T. G. Subramaniyan, N. Subramaniyan, and M. Chidambaram, "Brisk walking and yoga as adjuvant therapy in management of type 2 diabetes mellitus," International Journal of Students Research, vol. 2, no. 1, pp. 43-46, 2012.
61. K. Vaishali, K. V. Kumar, P. Adhikari, and B. UnniKrishnan, "Effects of yoga-based program on glycosylated hemoglobin level serum lipid profile in community dwelling elderly subjects with chronic type 2 diabetesmellitus-a randomized controlled trial," Physical and OccupationalTherapy in Geriatrics, vol. 30, no. 1, pp. 22-30, 2012.
62. K. Vaishali, K. V. Kumar, P. Adhikari, and B. Unni Krishnan, "Effects of yoga-based program on glycosylated hemoglobin level and serum lipid profile in community dwelling elderly subjects with chronic type 2 diabetes mellitus-a randomized controlled trial," Indian Journal of Ancient Medicine and Yoga, vol. 4, no. 2, pp. 69-76, 2011.
63. A. Pardasany, S. Shenoy, and J. S. Sandhu, "Comparing the efficacy of tai chi chuan and hatha yoga in type 2 diabetes mellitus patients on parameters of blood glucose control and lipid metabolism," Indian Journal of Physiotherapy and Occupational Therapy, vol. 4, no. 3, pp. 11-16, 2010.
64. S. Amita, S. Prabhakar, I. Manoj, S. Harminder, and T. Pavan, "Effect of Yoga-Nidra on blood glucose level in diabetic patients," Indian Journal of Physiology and Pharmacology, vol. 53, no. 1, pp. 97-101, 2009.
65. L. Skoro-Kondza, S. S. Tai, R. Gadelrab, D. Drincevic, and T. Greenhalgh, "Community based yoga classes for type 2 diabetes: an exploratory randomised controlled trial," BMC Health Services Research, vol. 9, article 33, 2009.
66. L. A. Gordon, E. Y. Morrison, D. A. McGrowder et al., "Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes," BMC Complementary and Alternative Medicine, vol. 8, article 21, 2008.
67. L. Gordon, E. Y. Morrison, D. A. McGrowder et al., "Changes in clinical and metabolic parameters after exercise therapy in patents with type 2 diabetes," Archives ofMedical Science, vol. 4, no. 4, pp. 427-437, 2008.
68. L. Gordon, E. Y. Morrison, D. McGrowder et al., "Effect of yoga and traditional physical exercise on hormones and percentage insulin binding receptor in patients with type 2 diabetes," American Journal of Biochemistry and Biotechnology, vol. 4, no. 1, pp. 35-42, 2008.
69. E. M. Cespedes, G. Riveron, C. A. Alonso, and L. Gordon, "Evolucion metabolica de pacientes diabeticos tipo 2 sometidos a un tratamiento combinado de dieta y ejercicios yoga," Revista Cubana de Investigaciones Biomedicas, vol. 21, no. 2, pp. 1-5, 2002.
70. R. Monro, J. Power, A. Coumar, R. Nagarathna, and P. Dandona, "Yoga therapy for NIDDM: a controlled trial," Complementary Medical Research, vol. 6, no. 2, pp. 66-68, 1992.
71. P. Chu, R. A. Gotink, G. Y. Yeh, S. J. Goldie, and M. G. M. Hunink, "The effectiveness of yoga inmodifying risk factors for cardiovascular disease and metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials," European Journal of Preventive Cardiology, 2014.
72. H. Cramer, H. Haller, R. Lauche, N. Steckhan, A. Michalsen, and G. Dobos, "A systematic review andmeta-analysis of yoga for hypertension," American Journal ofHypertension, vol. 27, no. 9, pp. 1146-1151, 2014.
73. M. Hagins, R. States, T. Selfe, and K. Innes, "Effectiveness of yoga for hypertension: systematic review and meta-analysis," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 649836, 13 pages, 2013.
74. A. Ceriello, "Oxidative stress and diabetes-associated complications," Endocrine Practice, vol. 12, supplement 1, pp. 60-62, 2006.
75. H. K. Vincent, K. E. Innes, and K. R. Vincent, "Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity," Diabetes, Obesity and Metabolism, vol. 9, no. 6, pp. 813-839, 2007.
76. K. E. Innes, H. K. Vincent, and A. G. Taylor, "Chronic stress and insulin-resistance-related indices of cardiovascular disease risk. Part I. Neurophysiological responses and pathological sequelae," AlternativeTherapies in Health and Medicine, vol. 13, no. 4, pp. 46-52, 2007.
77. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, "Diabetes, oxidative stress, and antioxidants: a review," Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24-38, 2003.
78. K. Stadler, "Oxidative stress in diabetes," inDiabetes Advances in Experimental Medicine and Biology, S. I. Ahmad, Ed., pp. 272-287, Landes Bioscience and Springer Science, New York, NY, USA, 2013.
79. A. Nouwen, K. Winkley, J. Twisk et al., "Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review andmeta-analysis," Diabetologia, vol. 53, no. 12, pp. 2480-2486, 2010.
80. K. E. Innes, T. K. Selfe, and A. G. Taylor, "Menopause, the metabolic syndrome, and mind-body therapies," Menopause, vol. 15, no. 5, pp. 1005-1013, 2008.
81. K. E. Innes, H. K. Vincent, and A. G. Taylor, "Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part I: neurophysiological responses and pathological sequelae," AlternativeTherapies in Health and Medicine, vol. 13, no. 4, pp. 46-52, 2007.
82. A. A. Weinstein, P. A. Deuster, and W. J. Kop, "Heart rate variability as a predictor of negative mood symptoms induced by exercise withdrawal," Medicine and Science in Sports and Exercise, vol. 39, no. 4, pp. 735-741, 2007.
83. S. H. Golden, "A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus," Current Diabetes Reviews, vol. 3, no. 4, pp. 252-259, 2007.
84. I. Kyrou, G. P. Chrousos, and C. Tsigos, "Stress, visceral obesity, and metabolic complications," Annals of the New York Academy of Sciences, vol. 1083, pp. 77-110, 2006.
85. L. P. Reagan, C. A. Grillo, and G. G. Piroli, "The As and Ds of stress:metabolic, morphological and behavioral consequences," European Journal of Pharmacology, vol. 585, no. 1, pp. 64-75, 2008.
86. B. T. Mausbach, S. Ancoli-Israel, R. von Känel et al., "Sleep disturbance, norepinephrine, and D-dimer are all related in elderly caregivers of people with Alzheimer disease," Sleep, vol. 29, no. 10, pp. 1347-1352, 2006.
87. B. S. McEwen, "Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load," Metabolism, vol. 55, no. 10, supplement 2, pp. S20-S23, 2006.
88. B. S. McEwen, "Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators," European Journal of Pharmacology, vol. 583, no. 2-3, pp. 174-185, 2008.
89. P. H. Whincup, S. J. Kaye, C. G. Owen et al., "Birth weight and risk of type 2 diabetes: a systematic review," The Journal of the American Medical Association, vol. 300, no. 24, pp. 2886-2897, 2008.
90. M. J. Knol, J. W. Twisk, A. T. Beekman, R. J. Heine, F. J. Snoek, and F. Pouwer, "Depression as a risk factor for the onset of type diabetes mellitus. A meta-analysis," Diabetologia, vol. 49, no. 5, pp, 837-845, 2006.
91. A.-K. Eriksson, A. Ekbom, F. Granath, A. Hilding, S. Efendic, and C.-G. Ostenson, "Psychological distress and risk of prediabetes and Type 2 diabetes in a prospective study of Swedish middle-agedmen and women," DiabeticMedicine, vol. 25, no. 7, pp. 834-842, 2008.
92. A. Engum, "The role of depression and anxiety in onset of diabetes in a large population-based study," Journal of Psychosomatic Research, vol. 62, no. 1, pp. 31-38, 2007.
93. E. C. Suarez, "Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity," Brain, Behavior, and Immunity, vol. 22, no. 6, pp. 960-968, 2008.
94. M. I. Trenell, N. S. Marshall, and N. L. Rogers, "Sleep and metabolic control:waking to a problem?" Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 1-2, pp. 1-9, 2007.
95. M. R. Irwin, M. Wang, D. Ribeiro et al., "Sleep loss activates cellular inflammatory signaling," Biological Psychiatry, vol. 64, no. 6, pp. 538-540, 2008.
96. C. Meisinger, M. Heier, and H. Loewel, "Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population," Diabetologia, vol. 48, no. 2, pp. 235-241, 2005.
97. P. M. Nilsson, M. Rööst, G. Engström, B. Hedblad, and G. Berglund, "Incidence of diabetes in middle-aged men is related to sleep disturbances," Diabetes Care, vol. 27, no. 10, pp. 2464-2469, 2004.
98. M. J. Knol, J. W. R. Twisk, A. T. F. Beekman, R. J. Heine, F. J. Snoek, and F. Pouwer, "Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis," Diabetologia, vol. 49, no. 5, pp. 837-845, 2006.
99. O. Chan, K. Inouye, M. C. Riddell, M. Vranic, and S. G. Matthews, "Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis,"Minerva Endocrinologica, vol. 28, no. 2, pp. 87-102, 2003.
100. R. S. Surwit, M. A. L. van Tilburg, N. Zucker et al., "Stress management improves long-term glycemic control in type 2 diabetes," Diabetes Care, vol. 25, no. 1, pp. 30-34, 2002.
101. E. B. Fisher, C. T. Thorpe, B. M. Devellis, and R. F. Devellis, "Healthy coping, negative emotions, and diabetesmanagement: a systematic review and appraisal," Diabetes Educator, vol. 33, no. 6, pp. 1080-1103, 2007.
102. P. A. Pirraglia and S. Gupta, "The interaction of depression and diabetes: a review," Current Diabetes Reviews, vol. 3, no. 4, pp. 249-251, 2007.
103. J. C. Konen, J. H. Summerson, and M. B. Dignan, "Family function, stress, and locus of control. Relationships to glycemia in adults with diabetes mellitus," Archives of Family Medicine, vol. 2, no. 4, pp. 393-402, 1993.
104. K. L. Knutson, E. Van Cauter, P. Zee, K. Liu, and D. S. Lauderdale, "Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes. The coronary artery risk development in young adults (CARDIA) sleep study," Diabetes Care, vol. 34, no. 5, pp. 1171-1176, 2011.
105. F. P. Cappuccio, L. DElia, P. Strazzullo, and M. A. Miller, "Sleep duration and all-causemortality: a systematic review andmetaanalysis of prospective studies," Sleep, vol. 33, no. 5, pp. 585-592, 2010.
106. X. Zhang, S. L. Norris, E. W. Gregg, Y. J. Cheng, G. Beckles, and H. S. Kahn, "Depressive symptoms and mortality among persons with and without diabetes," American Journal of Epidemiology, vol. 161, no. 7, pp. 652-660, 2005.
107. W. J. Katon, C. Rutter, G. Simon et al., "The association of comorbid depression with mortality in patients with type 2 diabetes," Diabetes Care, vol. 28, no. 11, pp. 2668-2672, 2005.
108. E. H. B. Lin, S. R. Heckbert, C. M. Rutter et al., "Depression and increased mortality in diabetes: unexpected causes of death," Annals of Family Medicine, vol. 7, no. 5, pp. 414-421, 2009.
109. W. Katon, M.-Y. Fan, J. Unützer, J. Taylor, H. Pincus, and M. Schoenbaum, "Depression and diabetes: a potentially lethal combination," Journal of General Internal Medicine, vol. 23, no. 10, pp. 1571-1575, 2008.
110. K.-M. Chen, M.-H. Chen, H.-C. Chao, H.-M. Hung, H.-S. Lin, and C.-H. Li, "Sleep quality, depression state, and health status of older adults after silver yoga exercises: cluster randomized trial," International Journal of Nursing Studies, vol. 46, no. 2, pp. 154-163, 2009.
111. K.-M. Chen, M.-H. Chen, M.-H. Lin, J.-T. Fan, H.-S. Lin, and C.-H. Li, "Effects of yoga on sleep quality and depression in elders in assisted living facilities," The Journal of Nursing Research, vol. 18, no. 1, pp. 53-61, 2010.
112. K.-Y. Lin, Y.-T. Hu, K.-J. Chang, H.-F. Lin, and J.-Y. Tsauo, "Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 659876, 12 pages, 2011.
113. K. E. Innes, H. K. Vincent, and A. G. Taylor, "Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: a potential role for mind-body therapies," Alternative Therapies in Health andMedicine, vol. 13, no. 5, pp. 44-51, 2007, Erratum in: Alternative Therapies in Health and Medicine, vol. 13, no. 6, p. 15, 2007.
114. C. C. Streeter, TheodoreH. Whitfield, L. Owen et al., "Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study," Journal of Alternative and Complementary Medicine, vol. 16, no. 11, pp. 1145-1152, 2010.
115. G. Kirkwood, H. Rampes, V. Tuffrey, J. Richardson, and K. Pilkington, "Yoga for anxiety: a systematic review of the research evidence," British Journal of Sports Medicine, vol. 39, no. 12, pp. 884-891, 2005.
116. K. E. Innes, T. K. Selfe, P. Agarwal, K. Williams, and K. L. Flack, "Efficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study," Journal of Alternative and ComplementaryMedicine, vol. 19, no. 6, pp. 527-535, 2013.
117. K. E. Innes and T. K. Selfe, "The effects of a gentle yoga program on sleep, mood, and blood pressure in older women with restless legs syndrome (RLS): a preliminary randomized controlled trial," Evidence-Based Complementary andAlternativeMedicine, vol. 2012, Article ID294058, 14 pages, 2012.
118. K. E. Innes, H. K. Vincent, and A. G. Taylor, "Chronic stress and insulin resistance-related indices of cardiovascular disease risk. Part 2. A potential role for mind-body therapies," Alternative Therapies in Health and Medicine, vol. 13, no. 5, pp. 44-51, 2007.
119. K. E. Innes and H. K. Vincent, "The influence of yogabased programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review," Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 469-486, 2007.
120. M. R. Carnethon, R. J. Prineas, M. Temprosa, Z.-M. Zhang, G. Uwaifo, and M. E. Molitch, "The association among autonomic nervous system function, incident diabetes, and intervention armin the diabetes prevention program," Diabetes Care, vol. 29, no. 4, pp. 914-919, 2006.
121. M. R. Carnethon, S. H. Golden, A. R. Folsom, W. Haskell, and D. Liao, "Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the atherosclerosis risk in communities study, 1987-1998," Circulation, vol. 107, no. 17, pp. 2190-2195, 2003.
122. R. B. Singh, C. Kartik, K. Otsuka, D. Pella, and J. Pella, "Brainheart connection and the risk of heart attack," Biomedicine and Pharmacotherapy, vol. 56, supplement 2, pp. 257s-265s, 2002.
123. R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, "The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis," Diabetes Care, vol. 26, no. 6, pp. 1895-1901, 2003.
124. D. Manzella and G. Paolisso, "Cardiac autonomic activity and type II diabetes mellitus," Clinical Science, vol. 108, no. 2, pp. 93-99, 2005.
125. K. E. Innes, C. Bourguignon, and A. G. Taylor, "Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review," Journal of the American Board of Family Practice, vol. 18, no. 6, pp. 491-519, 2005.
126. K. Innes, "Yoga-based programs for cardiovascular disease, diabetes, and related chronic conditions. Time for a new health care paradigm?" in Proceedings of the Yoga and Health: Research and Practice-An International Conference, London, UK, April 2014.
127. S. Tiwari, S. K. Tiwari, S. Gehlot, and G. Singh, "Outcome of breathing exercise (pranayam) on spirometric parameters in type 2 diabetic individuals: a clinical study," Journal of Stress Physiology and Biochemistry, vol. 8, no. 4, pp. 218-225, 2012.
128. D. A. Lawlor, S. Ebrahim, and G. D. Smith, "Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Womens Heart and Health study," Diabetologia, vol. 47, no. 2, pp. 195-203, 2004.
129. W. A. Davis, M. Knuiman, P. Kendall, V. Grange, and T. M. E. Davis, "Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study," Diabetes Care, vol. 27, no. 3, pp. 752-757, 2004.
130. E. S. Ford, D. M. Mannino, and National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study, "Prospective association between lung function and the incidence of diabetes: findings fromthe NationalHealth and Nutrition Examination Survey Epidemiologic Follow-up Study," Diabetes Care, vol. 27, no. 12, pp. 2966-2970, 2004.
131. T. M. McKeever, P. J. Weston, R. Hubbard, and A. Fogarty, "Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey," American Journal of Epidemiology, vol. 161, no. 6, pp. 546-556, 2005.
132. E. de G R Hansen and K. E. Innes, "The benefits of yoga for adults with type 2 diabetes: a review of the evidence and call for a collaborative, integrated research initiative," International Journal of YogaTherapy, vol. 23, no. 2, pp. 71-83, 2013.
133. K. E. Innes, C. Bourguignon, and A. G. Taylor, "Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review," The Journal of the American Board of Family Medicine, vol. 18, no. 6, pp. 491-519, 2005.
134. D. Khatri, K. C. Mathur, S. Gahlot, S. Jain, and R. P. Agrawal, "Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome," Diabetes Research and Clinical Practice, vol. 78, no. 3, pp. e9-e10, 2007.
135. I. Kyrou and C. Tsigos, "Stress mechanisms and metabolic complications," Hormone and Metabolic Research, vol. 39, no. 6, pp. 430-438, 2007.
136. I. Kyrou, G. P. Chrousos, and C. Tsigos, "Stress, visceral obesity, and metabolic complications," Stress, Obesity, and Metabolic Syndrome, vol. 1083, pp. 77-110, 2006.
137. R. P. Brown and P. L. Gerbarg, "SudarshanKriya yogic breathing in the treatment of stress, anxiety, and depression: part I-neurophysiologic model,"The Journal of Alternative and Complementary Medicine, vol. 11, no. 1, pp. 189-201, 2005, Erratum in:The Journal of Alternative and ComplementaryMedicine, vol. 11, no. 2, pp. 383-384, 2005.
138. R. McCaffrey, P. Ruknui, U. Hatthakit, and P. Kasetsomboon, "The effects of yoga on hypertensive persons in Thailand," Holistic Nursing Practice, vol. 19, no. 4, pp. 173-180, 2005.
139. K. Khattab, A. A. Khattab, J. Ortak, G. Richardt, and H. Bonnemeier, "Iyengar yoga increases cardiac parasympathetic nervous modulation among healthy yoga practitioners," Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 511-517, 2007.
140. R. E. De Meersman and P. K. Stein, "Vagal modulation and aging," Biological Psychology, vol. 74, no. 2, pp. 165-173, 2007.
141. J. F. Thayer and E. Sternberg, "Beyond heart rate variability," Annals of the New York Academy of Sciences, vol. 1088, pp. 361-372, 2006.
142. J. F. Thayer and R. D. Lane, "The role of vagal functioninthe risk for cardiovascular disease and mortality," Biological Psychology, vol. 74, no. 2, pp. 224-242, 2007.
143. D. J. J. Wang, H. Rao, M. Korczykowski et al., "Cerebral blood flow changes associated with different meditation practices and perceived depth of meditation," Psychiatry Research: Neuroimaging, vol. 191, no. 1, pp. 60-67, 2011.
144. A. B. Newberg, N. Wintering, M. R. Waldman, D. Amen, D. S. Khalsa, and A. Alavi, "Cerebral blood flow differences between long-term meditators and non-meditators," Consciousness and Cognition, vol. 19, no. 4, pp. 899-905, 2010.
145. K. Rubia, "The neurobiology of meditation and its clinical effectiveness in psychiatric disorders," Biological Psychology, vol. 82, no. 1, pp. 1-11, 2009.
146. T. W. Kjaer, C. Bertelsen, P. Piccini, D. Brooks, J. Alving, and H. C. Lou, "Increased dopamine tone during meditation-induced change of consciousness," Cognitive Brain Research, vol. 13, no. 2, pp. 255-259, 2002.
147. G. K. Alexander, K. E. Innes, T. K. Selfe, and C. J. Brown, "More than I expected: perceived benefits of yoga practice among older adults at risk for cardiovascular disease," Complementary Therapies in Medicine, vol. 21, no. 1, pp. 14-28, 2013.
148. M. A. Steinhardt, M. M. Mamerow, S. A. Brown, and C. A. Jolly, "A resilience intervention in African American adults with type diabetes: a pilot study of efficacy," Diabetes Educator, vol. 35, no. 2, pp. 274-284, 2009.
149. J. P. Yi, P. P. Vitaliano, R. E. Smith, J. C. Yi, and K. Weinger, "The role of resilience onpsychological adjustment andphysical health in patients with diabetes," British Journal of Health Psychology, vol. 13, no. 2, pp. 311-325, 2008.
150. N. Hartfiel, J. Havenhand, S. B. Khalsa, G. Clarke, and A. Krayer, "The effectiveness of yoga for the improvement of well-being and resilience to stress in the workplace," Scandinavian Journal ofWork, Environment and Health, vol. 37, no. 1, pp. 70-76, 2011.
151. J. Johnston, "The impact of yoga onmilitary personnelwith post traumatic stress disorder," Paper 29, Northeastern University, Boston, Mass, USA, 2011.
152. J. J. Noggle, N. J. Steiner, T. Minami, and S. B. S. Khalsa, "Benefits of yoga for psychosocial well-being in a us high school curriculum: a preliminary randomized controlled trial," Journal of Developmental and Behavioral Pediatrics, vol. 33, no. 3, pp. 193-201, 2012.
153. J. Dalen, B. W. Smith, B. M. Shelley, A. L. Sloan, L. Leahigh, and D. Begay, "Pilot study: mindful Eating and Living (MEAL): weight, eating behavior, and psychological outcomes associated with a mindfulness-based intervention for people with obesity," Complementary Therapies in Medicine, vol. 18, no. 6, pp. 260-264, 2010.
154. K. A. Dittmann and M. R. Freedman, "Body awareness, eating attitudes, and spiritual beliefs ofwomen practicingYoga," Eating Disorders, vol. 17, no. 4, pp. 273-292, 2009.
155. H. A. van Dam, F. G. van der Horst, L. Knoops, R. M. Ryckman, H. F. J. M. Crebolder, and B. H. W. van den Borne, "Social support in diabetes: a systematic review of controlled intervention studies," Patient Education and Counseling, vol. 59, no. 1, pp. 1-12, 2005.
156. T. S. Tang, M. B. Brown, M. M. Funnell, and R. M. Anderson, "Social support, quality of life, and self-care behaviors among african americans with type 2 diabetes," Diabetes Educator, vol. 34, no. 2, pp. 266-276, 2008.
157. L. Bernardi, M. Rosengård-Bärlund, and P.-H. Groop, "Cardiorespiratory interactions in diabetes," in Proceedings of the 8th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO 14), pp. 227-228, IEEE, Trento, Italy, May 2014.
158. L. Bernardi, G. Spadacini, J. Bellwon, R. Hajric, H. Roskamm, and A. W. Frey, "Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure," The Lancet, vol. 351, no. 9112, pp. 1308-1311, 1998.
159. L. Pomidori, F. Campigotto, T. M. Amatya, L. Bernardi, and A. Cogo, "Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study," Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 29, no. 2, pp. 133-137, 2009.
160. S. Cazzato, F. Bernardi, S. Salardi et al., "Lung function in children with diabetes mellitus," Pediatric Pulmonology, vol. 37, no. 1, pp. 17-23, 2004.
161. D. S. Black, S. W. Cole, M. R. Irwin et al., "Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial," Psychoneuroendocrinology, vol. 38, no. 3, pp. 348-355, 2013.
162. H. Lavretsky, E. S. Epel, P. Siddarth et al., "A pilot study of yogicmeditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity," International Journal ofGeriatric Psychiatry, vol. 28, no. 1, pp. 57-65, 2013.
163. J. A. Dusek, H. H. Otu, A. L. Wohlhueter et al., "Genomic counter-stress changes induced by the relaxation response," PLoS ONE, vol. 3, no. 7, Article ID e2576, 2008.
164. P. Kaliman, M. J. Alvarez-Lopez, M. Cosin-Tomás, M. A. Rosenkranz, A. Lutz, and R. J. Davidson, "Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators," Psychoneuroendocrinology, vol. 40, no. 1, pp. 96-107, 2014.
165. B. B. Lowell and G. I. Shulman, "Mitochondrial dysfunction and type 2 diabetes," Science, vol. 307, no. 5708, pp. 384-387, 2005.
166. K. E. Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes,"The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.